464 related articles for article (PubMed ID: 29400668)
1. Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils to Model Parkinson's Disease in Rodents.
Polinski NK; Volpicelli-Daley LA; Sortwell CE; Luk KC; Cremades N; Gottler LM; Froula J; Duffy MF; Lee VMY; Martinez TN; Dave KD
J Parkinsons Dis; 2018; 8(2):303-322. PubMed ID: 29400668
[TBL] [Abstract][Full Text] [Related]
2. A Summary of Phenotypes Observed in the In Vivo Rodent Alpha-Synuclein Preformed Fibril Model.
Polinski NK
J Parkinsons Dis; 2021; 11(4):1555-1567. PubMed ID: 34486988
[TBL] [Abstract][Full Text] [Related]
3. Combining fibril-induced alpha-synuclein aggregation and 6-hydroxydopamine in a mouse model of Parkinson's disease and the effect of cerebral dopamine neurotrophic factor on the induced neurodegeneration.
Singh A; Panhelainen A; Reunanen S; Luk KC; Voutilainen MH
Eur J Neurosci; 2024 Jan; 59(1):132-153. PubMed ID: 38072889
[TBL] [Abstract][Full Text] [Related]
4. The GBA1 D409V mutation exacerbates synuclein pathology to differing extents in two alpha-synuclein models.
Polinski NK; Martinez TN; Ramboz S; Sasner M; Herberth M; Switzer R; Ahmad SO; Pelligrino LJ; Clark SW; Marcus JN; Smith SM; Dave KD; Frasier MA
Dis Model Mech; 2022 Jun; 15(6):. PubMed ID: 35419585
[TBL] [Abstract][Full Text] [Related]
5. Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats.
Van Den Berge N; Ferreira N; Gram H; Mikkelsen TW; Alstrup AKO; Casadei N; Tsung-Pin P; Riess O; Nyengaard JR; Tamgüney G; Jensen PH; Borghammer P
Acta Neuropathol; 2019 Oct; 138(4):535-550. PubMed ID: 31254094
[TBL] [Abstract][Full Text] [Related]
6. Stereotaxic Targeting of Alpha-Synuclein Pathology in Mouse Brain Using Preformed Fibrils.
Zhang B; Kehm V; Gathagan R; Leight SN; Trojanowski JQ; Lee VM; Luk KC
Methods Mol Biol; 2019; 1948():45-57. PubMed ID: 30771169
[TBL] [Abstract][Full Text] [Related]
7. α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson's disease.
Cole TA; Zhao H; Collier TJ; Sandoval I; Sortwell CE; Steece-Collier K; Daley BF; Booms A; Lipton J; Welch M; Berman M; Jandreski L; Graham D; Weihofen A; Celano S; Schulz E; Cole-Strauss A; Luna E; Quach D; Mohan A; Bennett CF; Swayze EE; Kordasiewicz HB; Luk KC; Paumier KL
JCI Insight; 2021 Mar; 6(5):. PubMed ID: 33682798
[TBL] [Abstract][Full Text] [Related]
8. Differential α-synuclein expression contributes to selective vulnerability of hippocampal neuron subpopulations to fibril-induced toxicity.
Luna E; Decker SC; Riddle DM; Caputo A; Zhang B; Cole T; Caswell C; Xie SX; Lee VMY; Luk KC
Acta Neuropathol; 2018 Jun; 135(6):855-875. PubMed ID: 29502200
[TBL] [Abstract][Full Text] [Related]
9. Investigating key factors underlying neurodegeneration linked to alpha-synuclein spread.
Pang CCC; Sørensen MH; Lee K; Luk KC; Trojanowski JQ; Lee VMY; Noble W; Chang RCC
Neuropathol Appl Neurobiol; 2022 Oct; 48(6):e12829. PubMed ID: 35727707
[TBL] [Abstract][Full Text] [Related]
10. Effects of local reduction of endogenous α-synuclein using antisense oligonucleotides on the fibril-induced propagation of pathology through the neural network in wild-type mice.
Sano T; Nagata T; Ebihara S; Yoshida-Tanaka K; Nakamura A; Sasaki A; Shimozawa A; Mochizuki H; Uchihara T; Hasegawa M; Yokota T
Acta Neuropathol Commun; 2024 May; 12(1):75. PubMed ID: 38745295
[TBL] [Abstract][Full Text] [Related]
11. Alpha-synuclein-induced stress sensitivity renders the Parkinson's disease brain susceptible to neurodegeneration.
Nakos Bimpos M; Karali K; Antoniou C; Palermos D; Fouka M; Delis A; Tzieras I; Chrousos GP; Koutmani Y; Stefanis L; Polissidis A
Acta Neuropathol Commun; 2024 Jun; 12(1):100. PubMed ID: 38886854
[TBL] [Abstract][Full Text] [Related]
12. A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein.
Landeck N; Hall H; Ardah MT; Majbour NK; El-Agnaf OM; Halliday G; Kirik D
Mol Neurodegener; 2016 Aug; 11(1):61. PubMed ID: 27549140
[TBL] [Abstract][Full Text] [Related]
13. α-Synuclein pathology in Parkinson disease activates homeostatic NRF2 anti-oxidant response.
Delaidelli A; Richner M; Jiang L; van der Laan A; Bergholdt Jul Christiansen I; Ferreira N; Nyengaard JR; Vægter CB; Jensen PH; Mackenzie IR; Sorensen PH; Jan A
Acta Neuropathol Commun; 2021 Jun; 9(1):105. PubMed ID: 34092244
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Prolyl Oligopeptidase Restores Spontaneous Motor Behavior in the α-Synuclein Virus Vector-Based Parkinson's Disease Mouse Model by Decreasing α-Synuclein Oligomeric Species in Mouse Brain.
Svarcbahs R; Julku UH; Myöhänen TT
J Neurosci; 2016 Dec; 36(49):12485-12497. PubMed ID: 27927963
[TBL] [Abstract][Full Text] [Related]
15. How can rAAV-α-synuclein and the fibril α-synuclein models advance our understanding of Parkinson's disease?
Volpicelli-Daley LA; Kirik D; Stoyka LE; Standaert DG; Harms AS
J Neurochem; 2016 Oct; 139 Suppl 1(Suppl 1):131-155. PubMed ID: 27018978
[TBL] [Abstract][Full Text] [Related]
16. Oxidative and nitrative alpha-synuclein modifications and proteostatic stress: implications for disease mechanisms and interventions in synucleinopathies.
Schildknecht S; Gerding HR; Karreman C; Drescher M; Lashuel HA; Outeiro TF; Di Monte DA; Leist M
J Neurochem; 2013 May; 125(4):491-511. PubMed ID: 23452040
[TBL] [Abstract][Full Text] [Related]
17. Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies.
Brás IC; Outeiro TF
Cells; 2021 Feb; 10(2):. PubMed ID: 33673034
[TBL] [Abstract][Full Text] [Related]
18. Alpha synuclein dimers and oligomers are increased in overexpressing conditions in vitro and in vivo.
Marmolino D; Foerch P; Atienzar FA; Staelens L; Michel A; Scheller D
Mol Cell Neurosci; 2016 Mar; 71():92-101. PubMed ID: 26711807
[TBL] [Abstract][Full Text] [Related]
19. Social Cognition Impairments in Mice Overexpressing Alpha-Synuclein Under the Thy1 Promoter, a Model of Pre-manifest Parkinson's Disease.
Magen I; Torres ER; Dinh D; Chung A; Masliah E; Chesselet MF
J Parkinsons Dis; 2015; 5(3):669-680. PubMed ID: 25588356
[TBL] [Abstract][Full Text] [Related]
20. Detection of alpha-synuclein conformational variants from gastro-intestinal biopsy tissue as a potential biomarker for Parkinson's disease.
Ruffmann C; Bengoa-Vergniory N; Poggiolini I; Ritchie D; Hu MT; Alegre-Abarrategui J; Parkkinen L
Neuropathol Appl Neurobiol; 2018 Dec; 44(7):722-736. PubMed ID: 29676021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
